Gastro-intestinal System

Tagamet Syrup (Cimetidine)

Cimetidine is a histamine H₂ receptor antagonist.

Tagamet Syrup is indicated for:

The treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by Cimetidine has been shown to be beneficial: persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastrointestinal haemorrhage from stress ulceration in critically ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome.

Summary of Product Characteristics

Read this summary of product characteristics for further information about Tagamet Syrup. Click below to navigate to the EMC.

More info

Patient Information Leaflet

Read this patient information leaflet about Tagamet Syrup, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info

Gastro-intestinal System

Tagamet Syrup (Cimetidine)

Click here for Audio Version
Flavour	Peach
Storage Conditions	Store below 25°C
Sucrose Free
Shelf Life (Closed Bottle)	3 years
PIP Code	251173
EAN Code	5016119171390
Sodium Levels	12.8mg/5ml
Ethanol Concentration	118.1mg/5ml

Downloads

Patient Information Leaflet
Summary of Product Characteristics

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.